Modified GAF polypeptides

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530350, C07K 14475

Patent

active

055718957

ABSTRACT:
The present invention relates to a glia activating factor (GAF) in which 33 to 49 N-terminal amino acids are deleted from the N-terminus of the GAF polypeptide of SEQ ID NO: 3, as well as an anti-GAF antibody which is highly sensitive to assay the GAF and is capable of neutralizing GAF's activity, is produced.
Using the antibody, GAF and its biological activity can be assayed easily with high sensitivity. Further, the neutralizing antibody can be expected to have preventive and curative effects on diseases caused by GAF's excessive action. Furthermore, the GAF polypeptide disclosed herein is more stable to acids and heat than the conventional GAFs, therefore, it can be used as a platelet-increasing agent, etc., more advantageously than the previously known GAFs.

REFERENCES:
Ken-ichi Naruo et al.; J. Biol. Chem., 268, 2857 (1993).
Masaaki Miyamoto et al., Mol. Cell Biol., 13, 4251 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified GAF polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified GAF polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified GAF polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2015871

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.